decn

Healthcare

DECN Subsidiaries Appeal Nevada District Court Trial Judge’s Ruling to U.S. Court of Appeals for the Federal Circuit (The Patent Appeals Court)

December 21, 2018 admin Comments Off on DECN Subsidiaries Appeal Nevada District Court Trial Judge’s Ruling to U.S. Court of Appeals for the Federal Circuit (The Patent Appeals Court)

Companies Anticipate Another Precedential Ruling from the Federal Circuit Three Judge Panel Based on One Over-Arching Argument LOS ANGELES, CA / ACCESSWIRE / December 19, 2018 / Decision Diagnostics Corp. (otc pink:DECN) Decision Diagnostics Corp. […]

Healthcare

DECN Engages Second Korean Manufacturing Partner to Raise Its Factory Capacity by Two Million Boxes of ”GEN” Test Strips Annually

December 17, 2018 admin Comments Off on DECN Engages Second Korean Manufacturing Partner to Raise Its Factory Capacity by Two Million Boxes of ”GEN” Test Strips Annually

Company Also Readies Imminent Appeal in The Johnson & Johnson Patent Infringement Matter With The U.S. Court Of Appeals for The Federal Circuit LOS ANGELES, CA – December 17, 2018 Decision Diagnostics Corp. (OTC: DECN) […]

Healthcare

DECN Releases its Strategic IP And Product Development Introduction Plan With a Summary of 2018 Achievements and 2019 Expectations

December 11, 2018 admin Comments Off on DECN Releases its Strategic IP And Product Development Introduction Plan With a Summary of 2018 Achievements and 2019 Expectations

IP AND PRODUCTS STRATEGY IS PUT IN PLACE TO INCREASE REVENUES, BUILD THE BRAND AND POSITION THE COMPANY FOR A HANDSOME SETTLEMENT OR M&A TRANSACTION ++ LOS ANGELES, CA – December 11, 2018 – Decision Diagnostics […]

Healthcare

Decision Diagnostics Corp (OTC: DECN) Receives Completed Clinical Trials Report from its IRB and Anticipates Filing U.S. FDA 510k Application for its Genchoice! Product on December 21, 2018

December 4, 2018 admin Comments Off on Decision Diagnostics Corp (OTC: DECN) Receives Completed Clinical Trials Report from its IRB and Anticipates Filing U.S. FDA 510k Application for its Genchoice! Product on December 21, 2018

DECN Receives Completed Clinical Trials Report from its IRB and Anticipates Filing U.S. FDA 510k Application for its Genchoice! Product on December 21, 2018 December 04, 2018 — DECN to Launch Genchoice! Product in Select […]